Patent classifications
A23K20/10
Use of propyl propane thiosulfinate and propyl propane thiosulfonate for the prevention and reduction of parasites in aquatic animals
A method for reducing parasites in aquatic animals is provided. The method includes administering to the aquatic animal a compound comprising propyl propane thiosulfonate (PTSO) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 2 and also propyl propane thiosulfinate (PTS) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 1, so that a combination of PTS and PTSO is administered to the aquatic animal resulting in the reduction of a plurality of crustaceans infecting the aquatic animal in response to administering the combination of PTS and PTSO to the aquatic animal.
FEED SUPPLEMENT MATERIAL FOR USE IN AQUACULTURE FEED
The invention concerns a method of sustainably producing an aquaculture meat product by feeding a fish over its dietary cycles an aquaculture feed composition, said method comprising the step of formulating an aquaculture feed composition by replacing all or part of fish oil in the composition with a single microbial source of eicosapentaenoic acid (“EPA”) and docosahexaenoic acid (“DHA”). In a preferred embodiment, the microbial source comprising DHA and EPA derives from a microorganism/microbe of the genus Schizochytrium or Thraustochytrium.
FEED SUPPLEMENT MATERIAL FOR USE IN AQUACULTURE FEED
The invention concerns a method of sustainably producing an aquaculture meat product by feeding a fish over its dietary cycles an aquaculture feed composition, said method comprising the step of formulating an aquaculture feed composition by replacing all or part of fish oil in the composition with a single microbial source of eicosapentaenoic acid (“EPA”) and docosahexaenoic acid (“DHA”). In a preferred embodiment, the microbial source comprising DHA and EPA derives from a microorganism/microbe of the genus Schizochytrium or Thraustochytrium.
Method for evaluating food preference of pets
A method, a program, and a device for evaluating food preference of pets that do not require humans to eat a pet food itself. The preference of pets can be evaluated by conducting sensory analysis on selected palatants contained in a pet food by humans. Accordingly, highly precise prediction of the preference can be made by a simple and intuitive method based on sensory attributes for human. Further, humans are not required to eat a pet food itself because the humans may conduct sensory analysis on selected palatants contained in the pet food.
Method for evaluating food preference of pets
A method, a program, and a device for evaluating food preference of pets that do not require humans to eat a pet food itself. The preference of pets can be evaluated by conducting sensory analysis on selected palatants contained in a pet food by humans. Accordingly, highly precise prediction of the preference can be made by a simple and intuitive method based on sensory attributes for human. Further, humans are not required to eat a pet food itself because the humans may conduct sensory analysis on selected palatants contained in the pet food.
COMPOSITIONS AND METHODS FOR PROTECTING SAPONIN ACTIVITY
The invention is related to compositions including saponins and saponin-protective agents and related methods. In an embodiment, a composition is included herein. The composition can specifically include a saponin composition comprising saponins and a saponin-protective agent, wherein the saponin-protective agent prevents deglycosylation of the saponins in an aqueous environment containing glycosidase enzymes. Other embodiments are included herein.
COMPOSITIONS AND METHODS FOR PROTECTING SAPONIN ACTIVITY
The invention is related to compositions including saponins and saponin-protective agents and related methods. In an embodiment, a composition is included herein. The composition can specifically include a saponin composition comprising saponins and a saponin-protective agent, wherein the saponin-protective agent prevents deglycosylation of the saponins in an aqueous environment containing glycosidase enzymes. Other embodiments are included herein.
INSECT FEEDS
Insect feeds comprising a derivative of corn steep liquid are disclosed. Methods of feeding such insect feeds to insects such as bees, are further disclosed. In each of its various embodiments, the present invention fulfills these needs and discloses improved feeds to be fed to bees and other insects. In one embodiment, the insect feed comprises a derivative of corn steep liquid. The derivative of the corn steep liquid may be selected from the group consisting of a product derived from fermentation using media comprising a corn steep liquid, solids derived from a com steeping process, gluten water, corn steep liquor, grain distillers dried yeast, a microbial biomass, and combinations of any thereof.
INSECT FEEDS
Insect feeds comprising a derivative of corn steep liquid are disclosed. Methods of feeding such insect feeds to insects such as bees, are further disclosed. In each of its various embodiments, the present invention fulfills these needs and discloses improved feeds to be fed to bees and other insects. In one embodiment, the insect feed comprises a derivative of corn steep liquid. The derivative of the corn steep liquid may be selected from the group consisting of a product derived from fermentation using media comprising a corn steep liquid, solids derived from a com steeping process, gluten water, corn steep liquor, grain distillers dried yeast, a microbial biomass, and combinations of any thereof.
USES OF BACTEROIDES IN TREATMENT OR PREVENTION OF OBESITY AND OBESITY-RELATED DISEASES
Provided are uses of Bacteroides in preparation of a medicament. The medicament is for use in treatment or prevention of obesity-related diseases. Also provided are a pharmaceutical composition, a medicament, a food product, and an animal feed that comprise Bacteroides, uses thereof in treatment or prevention of obesity-related diseases, and a method for treatment or prevention of obesity-related diseases.